ADAR1 Capital Management, LLC bought $2.1M of Rallybio (RLYB)

Executed May 4, disclosed May 7, 2 days later.

Value, as filed

$2.1M

152,005 sh across 2 lots

Executed

May 4

the trade date, as filed

Disclosed

May 7

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+15.3%

+15.8% from execution

Over the 21 trading sessions from the disclosed entry session (May 6), the stock returned +15.3% (delay-adjusted); from the execution session (May 4), +15.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

AL ADAR1 Capital Management, LLC 10% owner profile →

ADAR1 Capital Management, LLC (10% owner) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 6 priced purchase filings, the average 21-session return was +9.6% from execution and +15.9% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4.

The name

RLYB

Rallybio Corporation RLYB · Healthcare · 4 filings in 24 months ticker →

Healthcare · Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by ADAR1 Capital Management, LLC in RLYB

RLYBPURCHASE Rallybio Corporation $140K
10,000 sh × $13.98
Exec May 19
Filed May 20 · 8:45 PM ET RLYBPURCHASE Rallybio Corporation $1.1M
75,178 sh × $14.00
Exec May 13
Filed May 15 · 8:49 PM ET RLYBPURCHASE Rallybio Corporation $629K
44,900 sh across 2 lots
Exec May 11
Filed May 13 · 9:22 PM ET